Literature DB >> 31351784

Changing epidemiology of immune-mediated inflammatory diseases in immigrants: A systematic review of population-based studies.

Manasi Agrawal1, Shailja Shah2, Anish Patel3, Rachel Pinotti4, Jean-Frederic Colombel5, Johan Burisch6.   

Abstract

BACKGROUND: Immune-mediated inflammatory diseases (IMIDs) are systemic diseases of multifactorial etiology that share aberrant immune responses as the common final pathway. With rising globalization, their incidence is increasing in developing countries and among immigrants. Our primary objective was to systematically review the epidemiology of IMIDs in immigrants and conduct a meta-analysis to estimate the risk of IMIDs in immigrant populations according to their origin and destination countries.
METHODS: We systematically searched five biomedical databases and reviewed population-based studies, from inception through August 2018, that reported incidence or prevalence data of inflammatory bowel disease (IBD), multiple sclerosis (MS), type 1 diabetes (T1D), systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), ankylosing spondylitis (AS) or psoriasis and psoriatic arthritis (PPA) among immigrants and the host population.
RESULTS: The incidence and prevalence of IMIDs among immigrants differ from host populations, and evolve over subsequent generations. The risk of IBD among immigrants approximates that in hosts, especially among South Asians, with ulcerative colitis incidence changing prior to Crohn's disease incidence. MS risk is highest in Iranian immigrants, T1D in African immigrants and SLE in African and Iraqi immigrants. Data on other IMIDs are sparse. Significant heterogeneity between the studies precluded meta-analysis.
CONCLUSION: Based on our systematic review, the epidemiology of IMIDs among immigrants varies according to native and host countries, immigrant generation, and IMID type. The rapid evolution suggests a role for non-genetic factors and gene-environment interactions. Future studies should focus on these pattern shifts, given implications of rising global burden of IMIDs and immigration.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoimmunity; Epidemiology; Immigration; Immune-mediated inflammatory diseases; Population-based studies; Systematic review

Year:  2019        PMID: 31351784     DOI: 10.1016/j.jaut.2019.07.002

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  5 in total

1.  A positive faecal immunochemical test result and its association with the incidence of rheumatoid arthritis, systemic lupus erythematosus, and psoriatic arthritis: an analysis of one-million national colorectal cancer screening programme results.

Authors:  Choong-Kyun Noh; Eunyoung Lee; Bumhee Park; Sung Soo Ahn
Journal:  BMC Med       Date:  2022-07-04       Impact factor: 11.150

2.  Current recommendations on the role of diet in the aetiology and management of IBD.

Authors:  Konstantinos Gerasimidis; Lihi Godny; Rotem Sigall-Boneh; Vaios Svolos; Catherine Wall; Emma Halmos
Journal:  Frontline Gastroenterol       Date:  2021-05-26

3.  Polysaccharide mycophenolate-based nanoparticles for enhanced immunosuppression and treatment of immune-mediated inflammatory diseases.

Authors:  Yuce Li; Yuchen Lou; Yu Chen; Jing Yang; Danqi Li; Biling Jiang; Jiajia Lan; Jingjing Wen; Yangxue Fu; Yamin Zhang; Juan Tao; Jintao Zhu
Journal:  Theranostics       Date:  2021-01-26       Impact factor: 11.556

4.  VIP/VPAC Axis Expression in Immune-Mediated Inflammatory Disorders: Associated miRNA Signatures.

Authors:  Amalia Lamana; David Castro-Vázquez; Hortensia de la Fuente; Ana Triguero-Martínez; Rebeca Martínez-Hernández; Marcelino Revenga; Raúl Villanueva-Romero; Mar Llamas-Velasco; Pablo Chicharro; Yasmina Juarranz; Mónica Marazuela; Marco Sales-Sanz; Rosario García-Vicuña; Eva Tomero; Isidoro González-Álvaro; Carmen Martínez; Rosa P Gomariz
Journal:  Int J Mol Sci       Date:  2022-08-02       Impact factor: 6.208

5.  Immune-mediated diseases are associated with a higher incidence of dementia: a prospective cohort study of 375,894 individuals.

Authors:  Ya-Ru Zhang; Liu Yang; Hui-Fu Wang; Bang-Sheng Wu; Shu-Yi Huang; Wei Cheng; Jian-Feng Feng; Jin-Tai Yu
Journal:  Alzheimers Res Ther       Date:  2022-09-13       Impact factor: 8.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.